Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma
Open Access
- 31 May 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6082
Abstract
We aimed to determine whether monitoring tumor-derived exosomal microRNAs (miRNAs) could be used to assess radiotherapeutic sensitivity in patients with locally advanced esophageal squamous cell carcinoma (ESCC). RNA sequencing was employed to conduct a comparative analysis of miRNA expression levels during radiotherapy, focusing on identifying miRNAs associated with progression. Electron microscopy confirmed the existence of exosomes, and co-cultivation assays and immunofluorescence validated their capacity to infiltrate macrophages. To determine the mechanism by which exosomal miR-143-3p regulates the interplay between ESCC cells and M2 macrophages, ESCC cell-derived exosomes were co-cultured with macrophages. Serum miR-143-3p and miR-223-3p were elevated during radiotherapy, suggesting resistance to radiation and an unfavorable prognosis for ESCC. Increased levels of both miRNAs independently predicted shorter progression-free survival (p = 0.015). We developed a diagnostic model for ESCC using serum microRNAs, resulting in an area under the curve of 0.751. Radiotherapy enhanced the release of miR-143-3p from ESCC cell-derived exosomes. Immune cell infiltration analysis at the Cancer Genome Atlas (TCGA) database revealed that ESCC cell-derived miR-143-3p triggered M2 macrophage polarization. Mechanistically, miR-143-3p upregulation affected chemokine activity and cytokine signaling pathways. Furthermore, ESCC cell exosomal miR-143-3p could be transferred to macrophages, thereby promoting their polarization. Serum miR-143-3p and miR-223-3p could represent diagnostic and prognostic markers for patients with ESCC undergoing radiotherapy. Unfavorable prognosis could be linked to the increased levels of ESCC cell-derived exosomal miR-143-3p, which might promote tumor progression by interacting with macrophages.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC3503200, 2023YFC3503205, 2021-I2M-1-018)
- Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) (2023YFC3503200, 2023YFC3503205, 2021-I2M-1-018)
This publication has 51 references indexed in Scilit:
- Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinomaCancer Cell, 2022
- Update on Management of Squamous Cell Esophageal CancerCurrent Oncology Reports, 2022
- Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophagesCancer Letters, 2020
- Current status of radiotherapy for patients with thoracic esophageal cancer in Japan, based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal SocietyEsophagus, 2019
- The role of exosomes and miRNAs in drug‐resistance of cancer cellsInternational Journal of Cancer, 2017
- Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancerBiomedicine & Pharmacotherapy, 2016
- Failure patterns in patients with esophageal cancer treated with definitive chemoradiationCancer, 2011
- Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by ?-catenin /TCF pathway in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Chemoradiotherapy of Locally Advanced Esophageal CancerJAMA, 1999